Stock 4536 SANTEN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Santen Pharmaceutical Co., Ltd.

Equities

4536

JP3336000009

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
1,512 JPY +1.41% Intraday chart for Santen Pharmaceutical Co., Ltd. +4.13% +7.65%
Mar. 26 Santen Pharmaceutical to Cancel 12 Million Treasury Shares MT
Mar. 25 Santen Announces Re-Designation Akira Kurokawa as Director of the Board and Chairman from Representative Director of the Board, Chairman, Effective from April 1, 2024 CI

Business Summary

SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.

Number of employees: 4,144

Sales per Business

JPY in Million2022Weight2023Weight Delta
Prescription Drugs
93.3 %
249,579 93.7 % 260,235 93.3 % +4.27%
Over-the-counter Drugs
3.8 %
9,780 3.7 % 10,628 3.8 % +8.67%
Medical Equipment
2.2 %
5,184 1.9 % 6,257 2.2 % +20.70%
Others
0.7 %
1,714 0.6 % 1,919 0.7 % +11.96%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
63.6 %
173,633 65.2 % 177,373 63.6 % +2.15%
EMEA
18.8 %
42,899 16.1 % 52,513 18.8 % +22.41%
Asia
8.6 %
19,813 7.4 % 24,118 8.6 % +21.73%
China
7.7 %
27,197 10.2 % 21,546 7.7 % -20.78%
Americas
1.3 %
2,715 1.0 % 3,488 1.3 % +28.47%

Managers

Managers TitleAgeSince
Takeshi Ito CEO
 Chief Executive Officer 64 82-03-31
Kazuo Koshiji DFI
 Director of Finance/CFO - -
Akira Kurokawa CHM
 Chairman 71 77-03-31
Mika Masunari CMP
 Compliance Officer - -
Minori Hara CTO
 Chief Tech/Sci/R&D Officer - -
Hidetaka Mizutani IRC
 Investor Relations Contact - -
Keizo Nakada PRN
 Corporate Officer/Principal - -
Ippei Kurihara SAM
 Sales & Marketing - -
Tomoki Yashiki HRO
 Human Resources Officer - -
Hiro Izaka AUD
 Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Akira Kurokawa CHM
 Chairman 71 77-03-31
Kanoko Oishi BRD
 Director/Board Member 63 15-05-31
Noboru Kotani BRD
 Director/Board Member 67 22-06-23
Yutaro Shintaku BRD
 Director/Board Member 68 17-05-31
Kunihito Minakawa BRD
 Director/Board Member 69 18-05-31
Takeshi Ito CEO
 Chief Executive Officer 64 82-03-31
Tamie Minami BRD
 Director/Board Member 65 22-06-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 363,996,254 341,047,590 ( 93.70 %) 12,792,169 ( 3.514 %) 93.70 %

Shareholders

NameEquities%Valuation
Nomura Asset Management Co., Ltd.
6.295 %
22,912,400 6.295 % 233 M ¥
Black Creek Investment Management, Inc.
5.725 %
20,839,347 5.725 % 212 M ¥
Silchester International Investors LLP
5.025 %
18,290,500 5.025 % 186 M ¥
Nippon Life Insurance Co.
2.929 %
10,662,000 2.929 % 108 M ¥
Nikko Asset Management Co., Ltd.
2.254 %
8,202,700 2.254 % 83 M ¥
MITSUBISHI UFJ FINANCIAL GROUP, INC
1.920 %
6,988,717 1.920 % 71 M ¥
Eisai Pension Fund
1.885 %
6,863,000 1.885 % 70 M ¥
ONO PHARMACEUTICAL CO., LTD.
1.704 %
6,204,000 1.704 % 63 M ¥
SPARX Asset Management Co., Ltd.
0.7115 %
2,589,800 0.7115 % 26 M ¥
TOKIO MARINE HOLDINGS, INC.
0.6754 %
2,458,300 0.6754 % 25 M ¥
NameEquities%Valuation
MFS Investment Management Canada Ltd.
0.0169 %
61,448 0.0169 % 603 542 ¥
RhumbLine Advisers LP
0.000008 %
30 0.000008 % 295 ¥

Holdings

NameEquities%Valuation
ONO PHARMACEUTICAL CO., LTD.
0.75%
 3,746,000 0.75% 60,752,291 $
EISAI CO., LTD.
0.32%
 949,500 0.32% 38,997,598 $
SANTEN PHARMACEUTICAL CO., LTD.
0.20%
 737,469 0.20% 7,487,007 $
MEDIPAL HOLDINGS CORPORATION
0.17%
 373,800 0.17% 5,730,059 $
MITSUBISHI UFJ FINANCIAL GROUP, INC
0.00%
 259,040 0.00% 2,664,939 $
SEIKAGAKU CORPORATION
0.73%
 415,600 0.73% 2,100,725 $
TOHO HOLDINGS CO., LTD.
0.09%
 69,050 0.09% 1,666,197 $
QD LASER, INC.
1.06%
 444,480 1.06% 1,597,657 $
SUZUKEN CO., LTD.
0.05%
 42,226 0.05% 1,294,304 $
VITAL KSK HOLDINGS, INC.
0.25%
 128,474 0.25% 1,066,195 $

Company contact information

Santen Pharmaceutical Co., Ltd.

Grand Front Osaka Tower A, 25/F 4-20 Ofuka-cho

530-8552, Osaka

+81 6 7664 8621

http://www.santen.co.jp
address Santen Pharmaceutical Co., Ltd.(4536)

Group companies

NameCategory and Sector
Santen Oy
Logo Santen Oy

Santen Oy

Pharmaceuticals: MajorHealth Technology

Santen Oy engages in the development, research, manufacture and marketing of pharmaceuticals, over-the-counter products, and medical devices. It specializes in ophthalmic pharmaceuticals. The company was founded on February 28, 1997 and is headquartered in Tampere, Finland.

Pharmaceuticals: Major
Santen Pharmaceutical Spain SL
Logo Santen Pharmaceutical Spain SL

Santen Pharmaceutical Spain SL

Medical DistributorsDistribution Services

Part of Santen Pharmaceutical Co., Ltd., Santen Pharmaceutical Spain SL wholesales pharmaceutical products. The private company is based in Las Rozas, Spain.

Medical Distributors

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Santen Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,512 JPY
Average target price
1,767 JPY
Spread / Average Target
+16.83%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SANTEN PHARMACEUTICAL CO., LTD. Stock Santen Pharmaceutical Co., Ltd.
+7.65% 3.5B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4536 Stock
  4. Company Santen Pharmaceutical Co., Ltd.